体外受精后临床妊娠女性的卵泡液抗苗勒管激素浓度更高:系统综述与荟萃分析
该系统综述与荟萃分析检索Medline、Embase和Cochrane数据库至2024年1月,纳入16项观察性研究共638例妊娠和1069例未妊娠女性,涵盖刺激(95.1%)与非刺激(4.9%)IVF方案。荟萃分析显示妊娠女性卵泡液抗苗勒管激素(ffAMH)平均浓度显著高于未妊娠女性(标准化均数差=0.76,95%CI 0.27-1.25;I²=83%,P<0.01),但研究间异质性大,需进一步研究后方可临床实施。
要点
- 妊娠女性卵泡液AMH平均浓度显著高于未妊娠女性(SMD=0.76,95%CI 0.27-1.25)。
- 研究间异质性较大(I²=83%,P<0.01),结论需谨慎解读。
- ffAMH可能作为颗粒细胞功能和卵母细胞质量的潜在标志物。
核心结论
- IVF后临床妊娠女性的卵泡液AMH平均浓度显著高于未妊娠女性(SMD=0.76,95%CI 0.27-1.25)。
- ffAMH可能作为颗粒细胞功能的标志物及卵母细胞质量的潜在指标。
- ffAMH有作为卵母细胞预后和选择标志物的前景,但研究间存在较大异质性,临床实施前需进一步研究。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、Embase和Cochrane数据库至2024年1月。
- 纳入观察性研究,分析ffAMH与IVF后临床妊娠率(CPR)的关联。
- 共纳入16项研究,含638例妊娠女性和1069例未妊娠女性。
- 研究涵盖刺激方案(95.1%)和非刺激方案(4.9%)的IVF。
主要发现
- 妊娠女性平均ffAMH浓度显著高于未妊娠女性(标准化均数差=0.76,95%CI 0.27-1.25;I²=83%,P<0.01)。
关键数值与推荐
- 妊娠女性vs未妊娠女性:ffAMH标准化均数差=0.76(95%CI 0.27-1.25;I²=83%,P<0.01),妊娠组更高。
临床怎么用
- ffAMH有作为卵母细胞预后和选择标志物的前景,但研究间异质性较大,临床实施前需进一步研究。
局限性
- 研究间存在较大异质性(I²=83%,P<0.01)。
- ffAMH作为预后和选择标志物有前景,但临床实施前需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anti-Müllerian hormone (AMH), produced by follicular granulosa cells, is a potential marker of granulosa cell function and may influence reproductive outcomes. A low concentration of AMH in follicular fluid (ffAMH) has been associated with granulosa cell dysfunction, but data on its association with the clinical pregnancy rate (CPR) after IVF remain limited and inconclusive. In order to address this research gap, the study question was formulated as follows: What is the association between ffAMH concentration and CPR after IVF? A systematic literature search was conducted in Medline, Embase and Cochrane databases until January 2024, including observational studies examining the association between ffAMH and CPR after IVF. Sixteen studies with 638 pregnant and 1069 non-pregnant women were analysed, encompassing both stimulated (95.1%) and non-stimulated (4.9%) IVF protocols. The meta-analysis revealed a significantly higher mean ffAMH concentration in pregnant women compared with non-pregnant women (standardized mean difference = 0.76, 95% CI 0.27-1.25; I² = 83%, P < 0.01). This finding suggests that ffAMH could serve as a marker for granulosa cell function and a potential indicator of oocyte quality. While ffAMH shows promise as a prognostic and selection marker for oocytes, the substantial heterogeneity across studies underscores the need for further research before clinical implementation.
引用
- Konrad D, Vidal A, Pape J, et al. Higher follicular fluid anti-Müllerian hormone concentration in women with clinical pregnancy after IVF: a systematic review and meta-analysis. Reprod Biomed Online. 2025. PMID: 40997488. doi:10.1016/j.rbmo.2025.105054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。